These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12722550)

  • 1. Impact of genetic polymorphisms on heart failure prognosis.
    Le Corvoisier P; Park HY; Carlson KM; Donahue MP; Marchuk DA; Rockman HA
    Arch Mal Coeur Vaiss; 2003 Mar; 96(3):197-206. PubMed ID: 12722550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifier genes and heart failure.
    Le Corvoisier P; Park HY; Rockman HA
    Minerva Cardioangiol; 2003 Apr; 51(2):107-20. PubMed ID: 12783067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy.
    Le Corvoisier P; Park HY; Carlson KM; Marchuk DA; Rockman HA
    Hum Mol Genet; 2003 Dec; 12(23):3097-107. PubMed ID: 14519689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics for neurohormonal intervention in heart failure.
    McNamara DM
    Heart Fail Clin; 2005 Apr; 1(1):141-50. PubMed ID: 17386840
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart failure and personalized medicine.
    Mestroni L; Merlo M; Taylor MR; Camerini F; Sinagra G
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):6-12. PubMed ID: 20814312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
    Franco E; Palumbo L; Crobu F; Anselmino M; Frea S; Matullo G; Piazza A; Trevi GP; Bergerone S
    BMC Med Genet; 2007 May; 8():27. PubMed ID: 17519002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure.
    Pop D; Zdrenghea D; Procociuc LM; Popal A
    Rom J Intern Med; 2007; 45(4):349-54. PubMed ID: 18767410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of heart failure in the course of coronary artery disease--the role of genetic factors].
    Kozieradzka A; Kamiński K; Musiał WJ
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S440-9. PubMed ID: 20527399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of heart failure -- focus on drug disposition and action.
    Cascorbi I; Paul M; Kroemer HK
    Cardiovasc Res; 2004 Oct; 64(1):32-9. PubMed ID: 15364611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.
    Mialet-Perez J; Liggett SB
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):616-20. PubMed ID: 16878723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular diseases and gene polymorphisms].
    Bartosová L; Strnadová V; Bartos M; Krcmár J; Necas J
    Cas Lek Cesk; 2006; 145(9):695-700; discussion 700-1. PubMed ID: 17091724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis.
    Kitsios G; Zintzaras E
    Am J Epidemiol; 2007 Sep; 166(6):619-33. PubMed ID: 17644825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution mapping of Cia3: a common arthritis quantitative trait loci in different species.
    Yu X; Teng H; Marques A; Ashgari F; Ibrahim SM
    J Immunol; 2009 Mar; 182(5):3016-23. PubMed ID: 19234197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure.
    Cuoco MA; Pereira AC; de Freitas HF; de Fátima Alves da Mota G; Fukushima JT; Krieger JE; Mansur AJ
    Int J Cardiol; 2005 Mar; 99(1):97-103. PubMed ID: 15721506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
    de Groote P; Mouquet F; Dallongeville J; Lamblin N; Bauters C
    Am Heart J; 2007 May; 153(5):e15. PubMed ID: 17452135
    [No Abstract]   [Full Text] [Related]  

  • 20. AMPD1 gene polymorphism and survival in patients with stable congestive heart failure.
    Palmer BR; Frampton CM; Richards AM; Cameron VA
    Am Heart J; 2007 May; 153(5):e13. PubMed ID: 17452134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.